Apr

12

TLR7 activation by LDV / R848 (Resiquimod) prevents acute graft versus host disease and cooperates with anti-IL-27 antibody for optimal protection

Donderdag 12 April 2018, van 17:00 tot 21:00

Lecturer

Mélanie GAIGNAGE (Promoter: Jean-Paul Coutelier, Co-promoter: Jacques Van Snick)
Gaignage

Plaats

de Visscher Auditorium
Avenue Hippocrate 74 (Ground Floor)
1200 Brussels
Belgium

Plaats

Hall DDUV
Avenue Hippocrate 75
1200 Brussels
Belgium